Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dabrafenibum - capsule rigide - dabrafenibum 50 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dabrafenibum - capsule rigide - dabrafenibum 75.0 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - trametinibum - compresse rivestite con film - trametinibum 0.5 mg ut trametinibi dimethylis sulfoxidi solvatum, mannitolum, cellulosum microcristallinum, hypromellosum, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis hydrica, magnesii stearas, Überzug: hypromellosum, macrogolum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.199 mg. - il melanoma non-tumori polmonari a piccole carcinoma polmonare - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - trametinibum - compresse rivestite con film - trametinibum 2 mg ut trametinibi dimethylis sulfoxidi solvatum, mannitolum, cellulosum microcristallinum, hypromellosum, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis hydrica, magnesii stearas, Überzug: hypromellosum, macrogolum, polysorbatum 80, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 0.232 mg. - il melanoma non-tumori polmonari a piccole carcinoma polmonare - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - erenumabum - soluzione iniettabile in siringa preriempita - erenumabum 70 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum, natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - erenumabum - soluzione iniettabile in penna preriempita - erenumabum 70 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - erenumabum - soluzione iniettabile in siringa preriempita - erenumabum 140 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum, natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - erenumabum - soluzione iniettabile in penna preriempita - erenumabum 140 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - oxcarbazepinum - compresse rivestite con film - oxcarbazepinum 300 mg, silica colloidalis anhydrica, crospovidonum, hypromellosum, magnesii stearas, cellulosum microcristallinum, Überzug: hypromellosum, macrogolum 8000, talcum, e 171, e 172 (flavum) pro compresso obducto. - antiepilepticum - synthetika